HR 2706
117th Congress
House
Health
Civil actions and liability
Congressional oversight
Government studies and investigations
Health care costs and insurance
Inflation and prices
Medicare
Prescription drugs
Freedom from Price Gouging Act
Introduced: April 20, 2021
See on congress.gov
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 21, 2021
Referred to the Subcommittee on Health.
Apr 20, 2021
Referred to the Subcommittee on Social Security.
Apr 20, 2021
Referred to the Subcommittee on Health.
Apr 20, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 20, 2021
Introduced in House
Plain-English summary
Freedom from Price Gouging Act
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
5